Review highlights advances and future needs in AL amyloidosis treatment
AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death.
Jun 26, 2024
0
49
Disease or Syndrome: Cardiac Amyloidosis
Medical news and research articles
Novel radiotracer produces high quality images of 'Alzheimer's disease of the heart'
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the "Alzheimer's disease of the heart." As the first amyloid-specific and pan-amyloid ...
Jun 10, 2024
0
22
Presence of carpal tunnel syndrome may indicate a high risk of developing cardiac amyloidosis
Physician-scientists from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine led a nationwide study to examine the role of carpal tunnel syndrome in predicting the risk of cardiac amyloidosis.
May 31, 2024
0
43
Researchers show genetic variant common among Black Americans contributes to large cardiovascular disease burden
Researchers at Brigham and Women's Hospital and Duke University showed that a genetic variant, present in 3-4% of self-identified Black individuals in the U.S., increases the risk for both heart failure and death and contributes ...
May 12, 2024
0
123
Cardiac amyloidosis: New AI system developed for early diagnosis
Cardiac amyloidosis is a serious disease in which abnormal proteins (amyloids) accumulate in the heart muscle and impair heart function. As the disease leads to serious complications such as heart insufficiency and, in many ...
Mar 21, 2024
0
31
Spotlight on early detection of three heart diseases using ECG-AI
Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest. Now, researchers and clinicians at Mayo Clinic are using artificial intelligence (AI) technology to flag ...
Feb 22, 2024
0
44
Cardiac amyloidosis: Why early diagnosis and targeted treatment matter
Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids can deposit in any tissue or organ, including the heart, kidneys, liver and nerves. When it occurs ...
Feb 22, 2024
0
46
Patisiran can preserve functional capacity in transthyretin amyloidosis, according to study
For patients with transthyretin amyloidosis (ATTR amyloidosis), administration of an RNA interference therapeutic agent, patisiran, over 12 months results in preserved functional capacity, according to a study published in ...
Oct 27, 2023
0
34
New molecule to fight against transthyretin amyloidosis
Researchers from IBB-UAB have developed a second-generation molecule that significantly improves the stabilization and inhibition of the aggregation of proteins involved in Transthyretin Amyloidosis (ATTR), a group of minority ...
Oct 18, 2023
0
35
First-of-its-kind study reveals predictive factors for outcomes of advanced stage AL amyloidosis
Early improvements in cardiac and hematologic parameters may predict better survival outcomes for patients being treated for stage IIIb AL amyloidosis, a deadly disease with a median survival of four to six months caused ...
Aug 15, 2023
0
27
